Page last updated: 2024-08-23

etoposide and zearalenone

etoposide has been researched along with zearalenone in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P	1
Cheng, J; Fan, Y; Jia, W; Kim, ES; Liang, L; Lu, F; Nuchtern, JG; Patel, RH; Vasudevan, SA; Xu, X; Yang, J; Zhang, H; Zhao, Y	1

Other Studies

2 other study(ies) available for etoposide and zearalenone

Article	Year
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22 Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship	2012
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy. Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:10 Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Heterografts; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Neuroblastoma; Signal Transduction; Zearalenone	2013

Article

Year

Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.

Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy.

Apoptosis : an international journal on programmed cell death, 2013, Volume: 18, Issue:10

Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Heterografts; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Nude; Neuroblastoma; Signal Transduction; Zearalenone

2013